Rankings
▼
Calendar
LAB FY 2024 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena
LAB
Standard BioTools Inc.
$388M
FY 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$174M
+64.0% YoY
Gross Profit
$84M
48.3% margin
Operating Income
-$175M
-100.5% margin
Net Income
-$139M
-79.6% margin
EPS (Diluted)
$-0.52
Cash Flow
Operating Cash Flow
-$143M
Free Cash Flow
-$152M
Stock-Based Comp.
$32M
Balance Sheet
Total Assets
$612M
Total Liabilities
$141M
Stockholders' Equity
$472M
Cash & Equivalents
$167M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$174M
$106M
+64.0%
Gross Profit
$84M
$50M
+67.0%
Operating Income
-$175M
-$77M
-128.8%
Net Income
-$139M
-$75M
-86.0%
← Q4 2023
All Quarters
Q1 2024 →